Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Ata de Congresso
|
447 Dual targeting of PD-1 and CTLA-4 synergizes with focal radiation to durably increase survival against glioblastomaDe Martino, Mara ; Daviaud, Camille ; Vanpouille-Box, ClaireJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A467-A467 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
12 |
Material Type: Ata de Congresso
|
1189 A GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesPascual-Pasto, Guillem ; McIntyre, Brendan ; Shraim, Rawan ; Buongervino, Samantha ; Erbe, Amy ; Jelev, Dontcho ; Giudice, Anna ; Martinez, Daniel ; Garcia-Gerique, Laura ; Dimitrov, Dimiter ; Sondel, Paul ; Bosse, KristopherJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1233-A1233 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
13 |
Material Type: Ata de Congresso
|
1323 CUE-102 selectively activates and expands WT1-specific T cells for the treatment of patients with WT1+ malignanciesGirgis, Natasha ; Yu, Christie ; Merazga, Zohra ; Hatfield, Steven ; Histed, Alex ; Zhao, Fan ; Moniz, Raymond ; Yeung, Kristin ; Diaz, Fulvio ; Bautista, Wynona ; Ross, John ; Cemerski, Saso ; Suri, Anish ; Levisetti, Matteo ; Quayle, StevenJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1374-A1374 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
14 |
Material Type: Ata de Congresso
|
203 Preclinical discovery and characterization of allogeneic anti-PSMA γδ CAR T therapy for prostate cancerRamadoss, Nitya ; Azameera, Aruna ; Teague, Alexander ; Wong, Jonathan ; Bagchi, Atrish ; Capillo, Tonya ; Smith-Boeck, Morgan ; Salum, Michael ; Meaddough, Erika ; Speltz, Elizabeth ; Hoopes, Matthew ; Wang, Katherine ; Kaur, Ramandeep ; Gundurao, Smitha ; Herrman, Marissa ; Chanthery, Yvan ; Blake, Aftab ; Nishimoto, Kevin ; Bhat, ArunJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A216-A216 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
15 |
Material Type: Ata de Congresso
|
1428 Melanocyte-intrinsic PDL1 promotes tumorigenesis and progression in a novel autochthonous melanoma modelOntiveros, Carlos ; Deng, Yilun ; Kornepati, Anand ; Murray, Clare ; Turk, Mary Jo ; Gupta, Harshita ; Padron, Alvaro ; Curiel, TylerJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1486-A1486 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
16 |
Material Type: Ata de Congresso
|
1148 Signal-regulatory protein alpha (SIRPα) confers tumor cell resistance to anti-tumor immunityChien-Huan Weng ; Hamadene, Linda ; Eghbali, Shabnam ; Venkatesh, Divya ; Monette, Sébastien ; Levi Mangarin ; Samaan, Fadi ; Liu, Cailian ; Holland, Pamela ; Wolchok, Jedd ; Taha MerghoubJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1191-A1191 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
17 |
Material Type: Ata de Congresso
|
76 Discovery of blood pharmacodynamic biomarkers for ATR inhibitorsKong, Ya ; Jiang, Lulu ; Jiang, Bin ; Hui Yuwen ; Mei, Jay ; Shan, Bo ; Hou, BingJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A82-A82 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
18 |
Material Type: Ata de Congresso
|
187 A live tumor fragment platform suitable for assessing response to T-cell therapiesZahm, Christopher ; Hrycyniak, Laura ; Wargowski, Ellen ; Joshi, Dinesh ; Team Adstamongkonkul ; Ochs, Greg ; Stueber, Gabriella ; Bloom, Debra ; Fischer, Ryan ; Scribano, Christina ; Johnson, Christin ; Shrestha, Anura ; Marhefke, Nathan ; Law, Ariah ; Oliner, JonathanJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A199-A199 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
19 |
Material Type: Ata de Congresso
|
885 Enhancing immune checkpoint inhibitor efficacy with anti-angiogenics in ovarian cancerGitto, Sarah ; Medvedev, Sergey ; Pandey, Veethika ; Omran, Dalia ; Anderson, Matthew ; Schwartz, Lauren ; Simpkins, Fiona ; Powell, DanielJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A922-A922 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
|
20 |
Material Type: Ata de Congresso
|
1391 ZM008 a first in class monoclonal anti LLT1 antibody demonstrated clinical potential in multiple solid cancersGhosh, Maloy ; Tiwari, Anurag ; Dubey, Ashvini ; Bhattacharjee, Sanghamitra ; Manjunath, Yogendra ; Kashipathi, Shalini ; Subith KrishnaJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1445-A1446 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |